RCRemy Chiaffarelli

Remy Chiaffarelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Remy Chiaffarelli has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Back Cover: A Macrocyclic Hybrid PET/MRI Probe for Quantitative Perfusion Imaging In Vivo (Angew. Chem. Int. Ed. 48/2024)

    by Jan Kretschmer, Remy Chiaffarelli, Marta Vuozzo, Jonathan Cotton, Jan Blahut, Jan Ráliš, Martin Dračínský, Stanislava Matějková, Ulrike Seeling, Andreas M. Schmid, et al.

  • Rücktitelbild: Eine makrozyklische Hybrid‐PET/MRT‐Sonde für die quantitative Perfusionsbildgebung in vivo (Angew. Chem. 48/2024)

    by Jan Kretschmer, Remy Chiaffarelli, Marta Vuozzo, Jonathan Cotton, Jan Blahut, Jan Ráliš, Martin Dračínský, Stanislava Matějková, Ulrike Seeling, Andreas M. Schmid, et al.

  • Open Access

    Eine makrozyklische Hybrid‐PET/MRT‐Sonde für die quantitative Perfusionsbildgebung in vivo

    by Jan Kretschmer, Remy Chiaffarelli, Marta Vuozzo, Jonathan Cotton, Jan Blahut, Jan Ráliš, Martin Dračínský, Stanislava Matějková, Ulrike Seeling, Andreas M. Schmid, et al.

    Die Perfusionsdynamik spielt eine entscheidende Rolle bei der Versorgung des Gewebes mit lebenswichtigen Nährstoffen und Sauerstoff und der Abführung von Stoffwechselendprodukten. Bildgebende Verfahren wie die Magnetresonanztomographie (MRT), die Computertomographie (CT) und die Positronen‐Emissions‐Tomographie (PET) verwenden Kontrastmittel, um Perfusions‐ und Ausscheidungsmuster sichtbar zu machen. Hybrid‐PET/MRT kombiniert die quantitativen Möglichkeiten und Empfindlichkeit der PET mit der hohen funktionellen und anatomischen Detailgenauigkeit der MRT und verspricht eine hohe Präzision bei der molekularen Bildgebung. Die Entwicklung von dualen PET/MRT‐Sonden wurde jedoch durch die anspruchsvolle Synthese und Markierung mit radioaktiven Isotopen erschwert. Hier stellen wir eine neuartige PET/MRT‐Sonde, [18F][Gd(FL1)], vor, die eine hervorragende Stabilität aufweist, die mit der von makrozyklischen MRT‐Kontrastmitteln vergleichbar ist, welche in der klinischen Praxis eingesetzt werden. Das einzigartige molekulare Design von [18F][Gd(FL1)] ermöglicht eine selektive und schnelle Markierung des Gadoliniumchelats im letzten Syntheseschritt. Durch die Nutzung der Stärken von MRT‐ und PET‐Signalen ermöglicht die Sonde eine quantitative in vivo‐Darstellung der Perfusions‐ und Ausscheidungsdynamik durch eine innovative voxelbasierte Analyse. Die diagnostischen Fähigkeiten von [18F][Gd(FL1)] wurden in einer Pilotstudie an gesunden Mäusen nachgewiesen, in der erfolgreich frühe Fälle von einseitiger Nierenfunktionsstörung, einer Erkrankung, die in der Regel schwer zu diagnostizieren ist, nachgewiesen wurden. Diese Studie stellt einen neuen Ansatz für PET/MRT vor und betont ein optimiertes Sondendesign für eine praktische Synthese und eine verbesserte diagnostische Genauigkeit.


  • Open Access

    A Macrocyclic Hybrid PET/MRI Probe for Quantitative Perfusion Imaging In Vivo

    by Jan Kretschmer, Remy Chiaffarelli, Marta Vuozzo, Jonathan Cotton, Jan Blahut, Jan Ráliš, Martin Dračínský, Stanislava Matějková, Ulrike Seeling, Andreas M. Schmid, et al.

    Perfusion dynamics play a vital role in delivering essential nutrients and oxygen to tissues while removing metabolic waste products. Imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) use contrast agents to visualize perfusion and clearance patterns; however, each technique has specific limitations. Hybrid PET/MRI combines the quantitative power and sensitivity of PET with the high functional and anatomical detail of MRI and holds great promise for precision in molecular imaging. However, the development of dual PET/MRI probes has been hampered by challenging synthesis and radiolabeling. Here, we present a novel PET/MRI probe, [ 18 F][Gd( FL 1 )], which exhibits excellent stability comparable to macrocyclic MRI contrast agents used in clinical practice. The unique molecular design of [ 18 F][Gd( FL 1 )] allows selective and expeditious radiolabeling of the gadolinium chelate in the final synthetic step. Leveraging the strengths of MRI and PET signals, the probe enables quantitative in vivo mapping of perfusion and excretion dynamics through an innovative voxel‐based analysis. The diagnostic capabilities of [ 18 F][Gd( FL 1 )] were demonstrated in a pilot study on healthy mice, successfully detecting early cases of unilateral renal dysfunction, a condition that is typically challenging to diagnose. This study introduces a new approach for PET/MRI and emphasizes a streamlined probe design for practical synthesis and improved diagnostic accuracy.


  • Open Access

    Metabolic PCTA-Based Shift Reagents for the Selective Detection of Extracellular Lactate Using CEST MRI

    by Remy Chiaffarelli, Pedro F. Cruz, Max Zimmermann, Carlos F. G. C. Geraldes, Paul Jurek, Andre F. Martins

    Lactate is a key metabolic driver in oncology and immunology. Even in the presence of physiological oxygen levels, most cancer cells upregulate anaerobic glycolysis, resulting in abnormal lactate production and accumulation in the tumor microenvironment. The development of more effective, sensitive, and safe probes for detecting extracellular lactate holds the potential to impact cancer metabolic profiling and staging significantly. Macrocyclic-based PARACEST agents have been reported to act as shift reagents (SRs) and detect extracellular lactate via CEST MRI. Here, we introduce a new family of SRs based on the PCTA ligand, an inherently stable and kinetically inert group of molecules with the potential for (pre)clinical translation. We observed that Yb-PCTA and Eu-PCTA can significantly shift lactate -OH signals in CEST spectra. In vitro, CEST MRI experiments proved that imaging extracellular lactate with these complexes is feasible and maintains high specificity even in the presence of competing small metabolites in blood and the tumor microenvironment. In vivo, preclinical imaging demonstrated that Yb-PCTA can be safely administered intravenously in mice to detect extracellular lactate non-invasively. This work represents a significant step towards precision and molecular imaging, demonstrating that the PCTA-ligand is a promising scaffold for developing molecular imaging sensors. These chemical sensors have broad medical applications, particularly in oncology and physiology.

  • Open Access

    Brain sex-dependent alterations after prolonged high fat diet exposure in mice

    by Valentina Murtaj, Silvia Penati, Sara Belloli, Maria Foti, Angela Coliva, Angela Papagna, Cecilia Gotti, Elisa Toninelli, Remy Chiaffarelli, Stefano Mantero, et al.

    We examined effects of exposing female and male mice for 33 weeks to 45% or 60% high fat diet (HFD). Males fed with either diet were more vulnerable than females, displaying higher and faster increase in body weight and more elevated cholesterol and liver enzymes levels. Higher glucose metabolism was revealed by PET in the olfactory bulbs of both sexes. However, males also displayed altered anterior cortex and cerebellum metabolism, accompanied by a more prominent brain inflammation relative to females. Although both sexes displayed reduced transcripts of neuronal and synaptic genes in anterior cortex, only males had decreased protein levels of AMPA and NMDA receptors. Oppositely, to anterior cortex, cerebellum of HFD-exposed mice displayed hypometabolism and transcriptional up-regulation of neuronal and synaptic genes. These results indicate that male brain is more susceptible to metabolic changes induced by HFD and that the anterior cortex versus cerebellum display inverse susceptibility to HFD.